Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Clinical Pharmacist

Opinion

Following social media use guidelines will ensure pharmacists do not fall foul of professional standards.

Don’t be scared to use social media professionallySubscription

By

Following social media use guidelines will ensure pharmacists do not fall foul of professional standards.

News in brief

The US Food and Drug Administration (FDA), pictured,  has approved palbociclib for metastatic breast cancer in postmenopausal women under its accelerated approval programme

Clinical Pharmacist's monthly news round-up: the top 10 in the past monthSubscription

What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.

Learning and CPD

Dialysis involves passing the patient’s blood against a semi-permeable membrane. The main options are haemodialysis (HD) pictured, using a dialysis machine and peritoneal dialysis (PD), which uses the patient’s peritoneum

Dialysis: principles and treatment optionsSubscription

By

How to choose between haemodialysis and peritoneal dialysis when starting renal replacement therapy.

Patients with end-stage renal disease require renal replacement therapy, such as dialysis, to replace the function of the kidneys. Patients will require clinical management to provide a number of small functions. In the image, a patient receives dialysis

Dialysis: managementSubscription

By

How to identify and manage potential complications and challenges presented by haemodialysis and peritoneal dialysis.

In the image, a colour x-ray of a coronary artery with Kawasaki disease, a type of vasculitis. Vasculitis is a collection of rare diseases characterised by the inflammation of blood vessel walls.

Managing ANCA-associated vasculitisSubscription

By ,

Treatment of vasculitis associated with antineutrophil cytoplasmic antibodies requires immunosuppressive therapies and close monitoring of the patient to manage toxicity.

Comment

Following social media use guidelines will ensure pharmacists do not fall foul of professional standards.

Don’t be scared to use social media professionallySubscription

By

Following social media use guidelines will ensure pharmacists do not fall foul of professional standards.

Columnist

David Gibson

Obtaining consent from patients is not always straightforwardSubscription

By

How do you obtain consent when the patient is unable to give it?

Update

The US Food and Drug Administration (FDA), pictured,  has approved palbociclib for metastatic breast cancer in postmenopausal women under its accelerated approval programme

Clinical Pharmacist's monthly news round-up: the top 10 in the past monthSubscription

What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.

Career development

Pharmacists were able to apply for a clinical doctoral research Fellowships from the National Institute for Health Research for the first time in 2014, giving them access to funding for an applied healthcare project.

How to secure funding from the National Institute for Health ResearchSubscription

By

Pharmacists were able to apply for clinical doctoral research Fellowships from the National Institute for Health Research for the first time in 2014, giving them access to funding for an applied healthcare project. With applications for 2015 now open, experts on the process share their advice.

Clinical Pharmacist

March 2015, Vol 7, No 2

Cover Story:

Choosing between haemodialysis and peritoneal dialysis and identifying potential complications.

Read more…

Clinical Pharmacist

View previous issue